Quarterly report · Q2
7363.TEDINET S100RPJC
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥575m | 2023-01-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥1.1bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥507m | 2022-01-01 → 2022-06-30 | Standalone | Net sales |
| Operating income | ¥14m | 2023-01-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | −¥3m | 2022-01-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | ¥14m | 2023-01-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥4m | 2022-01-01 → 2022-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥4m | 2023-01-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥4m | 2022-01-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | −¥11m | 2023-01-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | −¥5m | 2022-01-01 → 2022-06-30 | Standalone | Profit loss |
| Total assets | ¥1.1bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥1.1bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.2bn | at 2022-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥279m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥324m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥795m | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥806m | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥864m | at 2022-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥621m | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥716m | at 2022-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥621m | at 2023-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥716m | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥883m | at 2022-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-12-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥21m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥3m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥100m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥12m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥134m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥62m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥189m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥59m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-12.65 | 2023-01-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.7 | 2023-04-01 → 2023-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.94 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.61 | 2022-01-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.94 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.4 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| Equity ratio | 74.0% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.3% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.1% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 941,700 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 941,700 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 941,700 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 12
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥171m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥171m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥404m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥404m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥575m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥575m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥388m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥388m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥507m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥507m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 404
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |